Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Oct;65(10):4100–4107. doi: 10.1128/iai.65.10.4100-4107.1997

Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Y Han 1, T Kanbe 1, R Cherniak 1, J E Cutler 1
PMCID: PMC175590  PMID: 9317014

Abstract

We previously reported that the immunoglobulin M (IgM) monoclonal antibody (MAb) B6.1 protects mice against disseminated candidiasis, whereas the IgM MAb B6 does not. Both MAbs are specific for an adhesin fraction isolated from the cell surface of Candida albicans, but their epitope specificities differ. In the present study, we examined the surface locations of both epitopes and obtained structural information regarding the B6.1 epitope. Immunofluorescence confocal microscopic analysis of C. albicans yeast forms showed that epitope B6.1 is displayed rather homogeneously over the entire cell surface, whereas epitope B6 appears to have a patchy distribution. Both antibodies were essentially nonreactive with the surfaces of mycelial forms of the fungus, indicating that neither epitope is expressed on the surfaces of these forms. For isolation of the B6.1 epitope, the adhesin fraction consisting of cell surface phosphomannan was subjected to mildly acidic (10 mM HCl) hydrolysis and was fractionated into acid-labile and acid-stable portions by size exclusion chromatography. Antibody blocking experiments showed that the B6.1 epitope is an acid-labile moiety of the phosphomannan and that the B6 epitope is located in the acid-stable fraction. The B6 epitope appeared to be mannan because it was stable to heat (boiling) and protease treatments but was destroyed by alpha-mannosidase digestion. The B6.1 epitope eluted from the size exclusion column in two fractions. Mass spectroscopic analyses showed that one fraction contained material with the size of a mannotriose and that the other was a mixture of mannotriose- and mannotetraose-size substances. Dose response inhibition tests of the fractions indicated that the B6.1 epitope is associated with the mannotriose. Nuclear magnetic resonance (NMR) spectroscopic analysis of the epitope yielded data consistent with a beta-(1-->2)-linked mannotriose. The fine structure of the B6 epitope is under investigation. Information derived from these investigations will be useful both in understanding protective versus nonprotective antibody responses to C. albicans and in improving anti-Candida vaccine formulations.

Full Text

The Full Text of this article is available as a PDF (985.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brawner D. L., Cutler J. E. Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody. Infect Immun. 1984 Mar;43(3):966–972. doi: 10.1128/iai.43.3.966-972.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Casanova M., Martínez J. P., Chaffin W. L. Fab fragments from a monoclonal antibody against a germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans. Infect Immun. 1990 Nov;58(11):3810–3812. doi: 10.1128/iai.58.11.3810-3812.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cassone A., Boccanera M., Adriani D., Santoni G., De Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun. 1995 Jul;63(7):2619–2624. doi: 10.1128/iai.63.7.2619-2624.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cutler J. E. Putative virulence factors of Candida albicans. Annu Rev Microbiol. 1991;45:187–218. doi: 10.1146/annurev.mi.45.100191.001155. [DOI] [PubMed] [Google Scholar]
  5. Fradin C., Jouault T., Mallet A., Mallet J. M., Camus D., Sinaÿ P., Poulain D. Beta-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J Leukoc Biol. 1996 Jul;60(1):81–87. doi: 10.1002/jlb.60.1.81. [DOI] [PubMed] [Google Scholar]
  6. Han Y., Cutler J. E. Antibody response that protects against disseminated candidiasis. Infect Immun. 1995 Jul;63(7):2714–2719. doi: 10.1128/iai.63.7.2714-2719.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Han Y., Cutler J. E. Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis. 1997 May;175(5):1169–1175. doi: 10.1086/516455. [DOI] [PubMed] [Google Scholar]
  8. Hazen K. C., Brawner D. L., Riesselman M. H., Jutila M. A., Cutler J. E. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect Immun. 1991 Mar;59(3):907–912. doi: 10.1128/iai.59.3.907-912.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hazen K. C., Hazen B. W. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect Immun. 1992 Apr;60(4):1499–1508. doi: 10.1128/iai.60.4.1499-1508.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jouault T., Lepage G., Bernigaud A., Trinel P. A., Fradin C., Wieruszeski J. M., Strecker G., Poulain D. Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect Immun. 1995 Jun;63(6):2378–2381. doi: 10.1128/iai.63.6.2378-2381.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kanbe T., Han Y., Redgrave B., Riesselman M. H., Cutler J. E. Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect Immun. 1993 Jun;61(6):2578–2584. doi: 10.1128/iai.61.6.2578-2584.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kobayashi H., Giummelly P., Takahashi S., Ishida M., Sato J., Takaku M., Nishidate Y., Shibata N., Okawa Y., Suzuki S. Candida albicans serotype A strains grow in yeast extract-added Sabouraud liquid medium at pH 2.0, elaborating mannans without beta-1,2 linkage and phosphate group. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1003–1009. doi: 10.1016/0006-291x(91)91664-x. [DOI] [PubMed] [Google Scholar]
  13. Kobayashi H., Shibata N., Nakada M., Chaki S., Mizugami K., Ohkubo Y., Suzuki S. Structural study of cell wall phosphomannan of Candida albicans NIH B-792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid-labile oligomannosyl residues. Arch Biochem Biophys. 1990 Apr;278(1):195–204. doi: 10.1016/0003-9861(90)90248-w. [DOI] [PubMed] [Google Scholar]
  14. Kobayashi H., Takahashi S., Shibata N., Miyauchi M., Ishida M., Sato J., Maeda K., Suzuki S. Structural modification of cell wall mannans of Candida albicans serotype A strains grown in yeast extract-Sabouraud liquid medium under acidic conditions. Infect Immun. 1994 Mar;62(3):968–973. doi: 10.1128/iai.62.3.968-973.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Li R. K., Cutler J. E. Chemical definition of an epitope/adhesin molecule on Candida albicans. J Biol Chem. 1993 Aug 25;268(24):18293–18299. [PubMed] [Google Scholar]
  16. MOURAD S., FRIEDMAN L. Active immunization of mice against Candida albicans. Proc Soc Exp Biol Med. 1961 Mar;106:570–572. doi: 10.3181/00379727-106-26405. [DOI] [PubMed] [Google Scholar]
  17. Matthews R., Burnie J. P., Lee W. The application of epitope mapping in the development of a new serological test for systemic candidosis. J Immunol Methods. 1991 Sep 20;143(1):73–79. doi: 10.1016/0022-1759(91)90274-j. [DOI] [PubMed] [Google Scholar]
  18. Matthews R., Burnie J. Antibodies against Candida: potential therapeutics? Trends Microbiol. 1996 Sep;4(9):354–358. doi: 10.1016/0966-842x(96)10056-1. [DOI] [PubMed] [Google Scholar]
  19. Matthews R., Hodgetts S., Burnie J. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J Infect Dis. 1995 Jun;171(6):1668–1671. doi: 10.1093/infdis/171.6.1668. [DOI] [PubMed] [Google Scholar]
  20. Mourad S., Friedman L. Passive immunization of mice against Candida albicans. Sabouraudia. 1968 Feb;6(2):103–105. [PubMed] [Google Scholar]
  21. Nakajima T., Ballou C. E. Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation. J Biol Chem. 1974 Dec 10;249(23):7679–7684. [PubMed] [Google Scholar]
  22. Pearsall N. N., Adams B. L., Bunni R. Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol. 1978 Apr;120(4):1176–1180. [PubMed] [Google Scholar]
  23. Polonelli L., De Bernadis F., Conti S., Boccanera M., Magliani W., Gerloni M., Cantelli C., Cassone A. Human natural yeast killer toxin-like candidacidal antibodies. J Immunol. 1996 Mar 1;156(5):1880–1885. [PubMed] [Google Scholar]
  24. San Millan R., Ezkurra P. A., Quindós G., Robert R., Senet J. M., Pontón J. Effect of monoclonal antibodies directed against Candida albicans cell wall antigens on the adhesion of the fungus to polystyrene. Microbiology. 1996 Aug;142(Pt 8):2271–2277. doi: 10.1099/13500872-142-8-2271. [DOI] [PubMed] [Google Scholar]
  25. Shibata N., Hisamichi K., Kikuchi T., Kobayashi H., Okawa Y., Suzuki S. Sequential nuclear magnetic resonance assignment of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. Biochemistry. 1992 Jun 23;31(24):5680–5686. doi: 10.1021/bi00139a036. [DOI] [PubMed] [Google Scholar]
  26. Shibata N., Hisamichi K., Kobayashi H., Suzuki S. Complete assignment of 1H and 13C nuclear magnetic resonance chemical shifts of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. Arch Biochem Biophys. 1993 Apr;302(1):113–117. doi: 10.1006/abbi.1993.1188. [DOI] [PubMed] [Google Scholar]
  27. Shibata N., Ichikawa T., Tojo M., Takahashi M., Ito N., Okubo Y., Suzuki S. Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys. 1985 Dec;243(2):338–348. doi: 10.1016/0003-9861(85)90511-9. [DOI] [PubMed] [Google Scholar]
  28. Shibata N., Ikuta K., Imai T., Satoh Y., Satoh R., Suzuki A., Kojima C., Kobayashi H., Hisamichi K., Suzuki S. Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis. J Biol Chem. 1995 Jan 20;270(3):1113–1122. doi: 10.1074/jbc.270.3.1113. [DOI] [PubMed] [Google Scholar]
  29. Tavares D., Ferreira P., Vilanova M., Videira A., Arala-Chaves M. Immunoprotection against systemic candidiasis in mice. Int Immunol. 1995 May;7(5):785–796. doi: 10.1093/intimm/7.5.785. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES